Insiders · Profile

SHERWOOD CHARLES H

CEO and Director at Anika Therapeutics. Filing since 30 Jul 2007. CIK 0001244298

Company
Date
Role
Action
Shares
Amount
Of holding
24 Oct 2017
CEO and Director
Sold, plan not stated
3,278
$196.81K
2.4%
23 Oct 2017
CEO and Director
Sold, plan not stated
22,228
$1.34M
14.0%
20 Oct 2017
CEO and Director
Sold, plan not stated
5,991
$359.70K
3.6%
13 Oct 2017
CEO and Director
Sold, plan not stated
5,216
$313.53K
3.0%
12 Oct 2017
CEO and Director
Sold, plan not stated
1,908
$114.48K
1.1%
27 Jul 2017
CEO and Director
Sold, plan not stated
63,799
$3.24M
26.7%
5 Jul 2017
President, CEO, Director
Sold, plan not stated
8,236
$412.29K
3.3%
3 Jul 2017
President, CEO, Director
Sold, plan not stated
5,965
$298.25K
2.4%
1 May 2014
President and CEO
Sold, plan not stated
83,780
$3.71M
73.8%
28 Feb 2014
President and CEO
Sold, plan not stated
150,000
$6.16M
56.9%
27 Feb 2014
President and CEO
Sold, plan not stated
50,000
$2.18M
15.9%
15 Jul 2013
President and CEO
Sold, plan not stated
10,456
$215.71K
3.4%
12 Jul 2013
President and CEO
Sold, plan not stated
64,544
$1.29M
17.3%
9 Jul 2013
President and CEO
Sold, plan not stated
1,321
$23.92K
0.4%
8 Jul 2013
President and CEO
Sold, plan not stated
47,864
$864.42K
11.8%
5 Jul 2013
President and CEO
Sold, plan not stated
21,157
$381.04K
5.6%
3 Jul 2013
President and CEO
Sold, plan not stated
13,505
$243.23K
3.6%
19 Jun 2013
President and CEO
Sold, plan not stated
1,847
$33.25K
0.5%
14 Mar 2008
President & CEO
Sold, plan not stated
15,000
$130.61K
9.5%
13 Mar 2008
President & CEO
Sold, plan not stated
15,000
$138.61K
10.5%
12 Mar 2008
President & CEO
Sold, plan not stated
15,000
$139.50K
10.5%
11 Mar 2008
President & CEO
Sold, plan not stated
15,000
$145.80K
10.5%
31 Jul 2007
President & CEO
Sold, plan not stated
5,000
$100.10K
3.8%
30 Jul 2007
President & CEO
Sold, plan not stated
5,000
$100.02K
3.6%
24 decisions on file.